BiomX surges on merger deal with Adaptive Phage

BiomX surges on merger deal with Adaptive Phage
#earnings for the week https://t.co/lObOE0dgsr $NVDA $WMT $TGT $HD $RBLX $AMAT $CLSK $UWMC $NIU $PSFE $LOW $RAIL $CSCO $IDEX $M $TJX $DE $HUYA $DOYU $TME $OEG $KSS $POWW $BILI $VBLT $MBII $ZIM $A $EL $ADI $GRUB $DQ $MLSS $DRIO $FUV $FL $HHR $EAT $FTCH $SMED $PHGE $VIPS $TPR https://t.co/fijOtaE7S6
3.95MUSD
Type
Common Stock
Exchange
AMEX
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US09090D5095
CUSIP
09090D202
Sector
Industrials
Industry
Aerospace & Defense
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.35
Dividend Share
-
Dividend Yield
-
Earnings Share
-170.01
Wall Street Target Price
304.00
EPS Estimate Current Year
-58.50
EPS Estimate Next Year
-60.10
EPS Estimate Current Quarter
-5.06
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
332,000
Gross Profit TTM
97,000
EBITDA
-20,042,000
Profit Margin
0.00%
Return On Assets TTM
-42.35%
Return On Equity TTM
-247.34%
Revenue Per Share TTM
0.08
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-170.01
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
1.2745
Price Book MRQ
0.907
Enterprise Value Revenue
39
Enterprise Value EBITDA
0
230.86
0.40%147.08
-4.16%326.18
-2.57%93.66
-2.24%19.55
-2.10%525.07
-2.10%19.58
-1.90%206.99
-1.79%56.90
-1.39%198.12
-0.30%